Get the latest news on Xcelerate stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on XCRT performance

Latest Xcelerate Stock News | OTC:XCRT | Benzinga

Xcelerate Inc has assembled an internationally recognized team of translational clinicians, engineers and business leaders to identify, acquire, and develop engineering advancements, intellectual property and operating business in, or with applications in medical technology and clinical care. It intends to acquire innovation at the engineering/patent level, marry it with appropriate early-stage operational med-tech companies and apply it in a controlled clinical care setting which fosters engineering/clinical/business advancements under one umbrella.

Xcelerate Inc

News

Press Releases

Xcelerate, Inc. Announces That ESN Group, Inc. Has Gone Live on the Army & Air Force Exchange Service Online Exchange

Xcelerate, Inc. Announces That It Has Filed Its 2023 Annual Report

Xcelerate, Inc. Announces Change of Auditors

Xcelerate, Inc. Addresses Concerns About Recently Released Research Report

Xcelerate, Inc. Retains Investment Bank Craft Capital Management to Provide Investment Banking and Up-Listing Advisory Services

Xcelerate, Inc. Releases Shareholder Update

Xcelerate, Inc. Announces Commencement of the Nationalization Process for its PCT International Patent Applications

Comments

Xcelerate Stock News

News

Latest Xcelerate Stock News | OTC:XCRT | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga